These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25736544)

  • 1. Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves' disease.
    Li X; Wang G; Lu Z; Chen M; Tan J; Fang X
    J Endocrinol Invest; 2015 Jul; 38(7):753-9. PubMed ID: 25736544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
    Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
    Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum fibroblast growth factor 23 and mineral metabolism in patients with euthyroid Graves' diseases: a case-control study.
    Lin CH; Chang CK; Shih CW; Li HY; Chen KY; Yang WS; Tsai KS; Wang CY; Shih SR
    Osteoporos Int; 2019 Nov; 30(11):2289-2297. PubMed ID: 31384956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy and Graves' disease - Myths and reality.
    Plazinska MT; Sawicka-Gutaj N; Czarnywojtek A; Wolinski K; Kobylecka M; Karlińska M; Prasek K; Zgorzalewicz-Stachowiak M; Borowska M; Gut P; Ruchala M; Krolicki L
    PLoS One; 2020; 15(1):e0226495. PubMed ID: 31929534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease.
    Bogazzi F; Bartalena L; Campomori A; Brogioni S; Traino C; De Martino F; Rossi G; Lippi F; Pinchera A; Martino E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4490-5. PubMed ID: 12364424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Lugol's solution on
    Chai J; Zhang R; Zheng W; Zhang G; Jia Q; Tan J; Meng Z; Wang R
    Clin Exp Med; 2023 Jul; 23(3):825-831. PubMed ID: 35840869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine therapy in Graves' disease: is it possible to predict outcome before therapy?
    Isgoren S; Daglioz Gorur G; Demir H; Berk F
    Nucl Med Commun; 2012 Aug; 33(8):859-63. PubMed ID: 22669051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
    Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
    Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factor analysis in 325 patients with Graves' disease treated with radioiodine therapy.
    Yang D; Xue J; Ma W; Liu F; Fan Y; Rong J; Yang A; Yu Y
    Nucl Med Commun; 2018 Jan; 39(1):16-21. PubMed ID: 29040161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of radiation-induced Graves' disease in patients treated with radioiodine for thyroid autonomy before and after introduction of a high-sensitivity TSH receptor antibody assay.
    Dunkelmann S; Wolf R; Koch A; Kittner C; Groth P; Schuemichen C
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1428-34. PubMed ID: 15221291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies of radioiodine therapy for Graves' disease.
    Lind P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S453-7. PubMed ID: 12192545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].
    Sabri O; Schulz G; Zimny M; Schreckenberger M; Zimny D; Wagenknecht G; Kaiser HJ; Dohmen BM; Bares R; Büll U
    Nuklearmedizin; 1998 May; 37(3):83-9. PubMed ID: 9604227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25-hydroxyvitamin D might be an independent prognostic factor for Graves disease recurrence.
    Ahn HY; Chung YJ; Cho BY
    Medicine (Baltimore); 2017 Aug; 96(31):e7700. PubMed ID: 28767604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
    Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
    Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower Serum 25-Hydroxyvitamin D Level is Associated With 3 Types of Autoimmune Thyroid Diseases.
    Ma J; Wu D; Li C; Fan C; Chao N; Liu J; Li Y; Wang R; Miao W; Guan H; Shan Z; Teng W
    Medicine (Baltimore); 2015 Sep; 94(39):e1639. PubMed ID: 26426654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors of outcomes in personalized radioactive iodine ((131)I) treatment for Graves' disease.
    Liu M; Jing D; Hu J; Yin S
    Am J Med Sci; 2014 Oct; 348(4):288-93. PubMed ID: 24805788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radioiodine therapy of autonomously functioning thyroid nodules and Graves' disease].
    Guhlmann CA; Rendl J; Börner W
    Nuklearmedizin; 1995 Feb; 34(1):20-3. PubMed ID: 7724360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of
    Happel C; Kranert WT; Gröner D; Baumgarten J; Halstenberg J; Bockisch B; Sabet A; Grünwald F
    Endocrine; 2021 Jul; 73(1):125-130. PubMed ID: 33439464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of short-term treatment with lithium carbonate on the outcome of radioiodine therapy in patients with long-lasting Graves' hyperthyroidism.
    Sekulić V; Rajić M; Vlajković M; Ilić S; Stević M; Kojić M
    Ann Nucl Med; 2017 Dec; 31(10):744-751. PubMed ID: 28895066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.